Halliburton Beat Streak Thins as Insiders Pocket $7.7M
Three Halliburton executives sold $7.7 million in shares at $35-$37.50 in August 2026; the stock has since fallen to $32.55. More troubling is the EPS beat margin compression from 25.6% to 1.9%, testi
HAL Beat Streak Thins as Insiders Pocket $7.7M
NEW YORK, October 12 —
The CEO, COO, and CFO of Halliburton Company (HAL) sold a combined $7.70 million in shares in August 2026 at $35.00, $37.50, and the stock has since fallen to $32.55, below every sale price. Over the same stretch, the quarterly EPS beat margin compressed from 25.6% to 1.9%, testing the credibility of a $43.40 analyst consensus target.
- CEO, COO, and CFO sold $7.70M combined in August 2026 at $35.00, $37.50; HAL has since fallen to $32.55.
- EPS beat margin compressed from 25.6% in Q4 2025 to 1.9% in Q2 2026 over four consecutive beats.
- Trailing FCF of $2.05B and operating cash flow of $2.75B sit against $8.20B total debt; forward P/E is 11.2x.
Three Exits, Zero Buys
Halliburton operates two segments: Completion and Production, which covers stimulation services, cementing, artificial lift equipment and specialty chemicals, and Drilling and Evaluation, which covers drill bits, wireline services and cloud-based AI tools for subsurface analytics. Three senior executives cut their holdings in August 2026 at $35.00, $37.50 per share, with no purchases recorded. The stock has since fallen to $32.55. The $43.40 analyst consensus implies those executives left roughly $6, $8 per share in potential upside; either the target is detached from operational reality, or three officers who run the company made a costly collective error.
The Beat Trail Runs Cold
Halliburton has beaten EPS estimates four consecutive quarters, but the shrinking margin of each beat is now the story. The beat margin peaked at 25.6% in Q4 2025, fell to 10.0% in Q1 2026, and landed at 1.9% in Q2 2026 against a consensus estimate, per the Q2 8-K. With $22.37 billion in trailing revenue growing at 3.7%, the core business is not distressed. A beat trajectory compressing at this pace rarely reverses without a catalyst, and a first miss in Q3 would reprice HAL faster than any beat in this streak has re-rated it.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| HAL | $27.2B | 11.2x | +44.7% |
| SLB | $72.6B | 15.3x | +51.7% |
| RIG | $6.2B | 19.3x | +72.2% |
| COP | $161.1B | 13.3x | +51.0% |
| DVN | $53.1B | 9.0x | +45.3% |
| VLO | $124.9B | 10.1x | +168.7% |
One Number Will Settle It
At 11.2x forward earnings, Halliburton is not expensive, but oilfield services multiples contract when earnings-surprise momentum fades, and the balance sheet adds another constraint. With $8.20 billion in total debt against $2.05 billion in cash, net leverage runs roughly 3x trailing free cash flow, limiting room for buybacks to support the stock. The Q3 beat margin is the real checkpoint: a result near 10% would suggest the compression has found a floor; a fourth consecutive decline confirms what three C-suite executives signaled when they sold in August. Investors can stress-test the valuation using the DCF calculator. Run the free Halliburton Company deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Did Halliburton insiders buy or sell stock in August?
Three Halliburton executives, including the CEO, COO, and CFO, sold a combined $7.70 million in shares in August 2026 at $35.00, $37.50 per share. No insider purchases were recorded, and the stock has since declined to $32.55, validating their exit timing.
Has Halliburton's earnings beat margin been declining?
Yes. Halliburton's quarterly EPS beat margin compressed from 25.6% in Q4 2025 to 1.9% in Q2 2026 over four consecutive beats. This compressing trajectory rarely reverses without a catalyst, and a first miss in Q3 would likely reprice the stock faster than any beat in this streak has.
What is Halliburton's analyst price target?
The analyst consensus target is $43.40 per share. The three executives who sold in August at $35-$37.50 left roughly $6, $8 per share in theoretical upside on the table, raising questions about whether the target is realistic.
How much debt does Halliburton carry?
Halliburton has $8.20 billion in total debt against $2.05 billion in cash, with net leverage running roughly 3x trailing free cash flow. This debt level constrains the balance sheet and limits buyback capacity despite the stock trading at 11.2x forward earnings.
What is Halliburton's revenue and growth rate?
Halliburton has $22.37 billion in trailing revenue growing at 3.7 percent. While the core business is not distressed, the compression of earnings-beat margins suggests the momentum narrative may be weakening.
Halliburton's CEO, COO, and CFO collectively sold $7.70 million in open-market shares in August 2026 at prices between $35.00 and $37.50 — and the stock has since declined to $32.55, below every executive sale price. The sales coincide with a quarterly EPS beat margin that has compressed from 25.6% to 1.9% over three quarters, while analyst consensus still targets $43.40.